19 completed, 8 terminated, 4 active not recruiting, 2 not yet recruiting. 37 Phase 1, 12 Phase 2.
Follow Osteochondrodysplasias: new trials by email Literature Review of Osteochondrodysplasias trials Research Report on Osteochondrodysplasias
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI) Bone marrow-derived mesenchymal stromal cells (MSCs) - Osteogenesis Imperfecta, Osteogenesis Imperfecta Type III | Phase 1 / Phase 2 | Not yet recruiting | Emory University | 12 | 2027-01-01 | 2026-05-08 |
| Gene-Modified Stem Cell Therapy for Children With Autosomal Recessive Osteopetrosis (ARO) FT024 - Osteopetrosis | Phase 1 / Phase 2 | Recruiting | Fondazione Telethon | 8 | 2026-06-20 | 2026-06-24 |
| A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in Children With Achondroplasia ABSK061 - Achondroplasia | Phase 1 / Phase 2 | Not yet recruiting | Abbisko Therapeutics Co, Ltd | 110 | 2025-12-10 | 2025-12-22 |
| An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors HCB301 - Advanced Solid Tumor, Refractory Hodgkin Lymphoma | Phase 1 | Recruiting | FBD Biologics Limited | 50 | 2025-04-02 | 2026-04-13 |
| Metformin Repurposing in Oral Submucous Fibrosis: Unveiling In Vitro Signaling Pathways, Progressing to Clinical Trial Metformin Hydrochloride, betamethasone dipropionate, Pentoxifylline - Oral Submucous Fibrosis | Phase 1 / Phase 2 | Completed | Ziauddin University | 30 | 2024-08-12 | 2025-05-02 |
| A First-in-Human Study Evaluating AGA2115 in Adult Healthy Volunteers AGA2115, Placebo - Osteogenesis Imperfecta | Phase 1 | Completed | Angitia Incorporated Limited | 72 | 2023-10-03 | 2025-01-10 |
| A First-in-Human Phase 1 Study of Plasmalogen Precursor PPI-1011 in Healthy Adult Volunteers to Assess Safety, Tolerability, and Pharmacokinetics PPI-1011, Placebo - Rhizomelic Chondrodysplasia Punctata | Phase 1 | Completed | MED-LIFE DISCOVERIES LP | 56 | 2023-06-28 | 2026-10-09 |
| Bioequivalence Study to Compare Two Injection Devices for BMN 111 in Healthy Participants BMN 111 administration via Injector Pen, BMN 111 administration via vial and syringe - Achondroplasia | Phase 1 | Terminated | BioMarin Pharmaceutical | 36 | 2023-03-15 | 2023-10-12 |
| Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI) SAR439459, Placebo - Osteogenesis Imperfecta | Phase 1 | Terminated | Sanofi | 16 | 2022-08-25 | 2025-09-11 |
| Study of TST005 in Patients With Locally Advanced or Metastatic Solid Tumors TST005 - Locally Advanced or Metastatic Cancers, Metastatic Human Papillomavirus-Related Malignant Neoplasm | Phase 1 | Terminated | Transcenta Therapeutics (Hangzhou) Co., Ltd. | 19 | 2021-06-11 | 2023-10-23 |
| Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta Romosozumab, Calcium, Vitamin D - Osteogenesis Imperfecta | Phase 1 | Completed | Amgen | 25 | 2021-01-21 | 2024-04-15 |
| A First-in-human Single and Repeated Dose Escalation Study of SAR442501 in Healthy Adults Subjects SAR442501, Placebo - Osteochondrodysplasia | Phase 1 | Completed | Sanofi | 76 | 2020-11-18 | 2024-08-27 |
| Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046) M7824, Carboplatin, Paclitaxel - Cervical Cancer | Phase 1 | Completed | EMD Serono Research & Development Institute, Inc. | 25 | 2020-10-19 | 2024-03-08 |
| Losartan to Improve Hip Microfracture Losartan, Placebo - Hip Osteoarthritis, Hip Impingement Syndrome | Phase 1 / Phase 2 | Terminated | Steadman Philippon Research Institute | 1 | 2020-08-07 | 2023-10-30 |
| Bioimaging Study of 89Zr-M7824 in NSCLC 89Zirconium-M7824, M7824 - Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | Terminated | Olivia Newton-John Cancer Research Institute | 5 | 2020-06-01 | 2023-01-17 |
| A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer LY3200882, Pembrolizumab - Advanced Cancer | Phase 1 / Phase 2 | Withdrawn | Eli Lilly and Company | 2019-12-05 | 2020-02-19 | |
| Boost Brittle Bones Before Birth BOOST cells - Osteogenesis Imperfecta | Phase 1 / Phase 2 | Active not recruiting | Karolinska Institutet | 18 | 2019-08-12 | 2025-09-12 |
| Boost to Brittle Bones - Stem Cell Transplantation for Treatment of Brittle Bones BOOST cells - Osteogenesis Imperfecta | Phase 1 / Phase 2 | Unknown | Christian Medical College, Vellore, India | 15 | 2019-05-20 | 2020-11-10 |
| PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors PF-06952229, Enzalutamide - Breast Neoplasms, Prostate Neoplasms | Phase 1 | Terminated | Pfizer | 49 | 2018-10-04 | 2024-06-26 |
| Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta Fresolimumab - Osteogenesis Imperfecta | Phase 1 | Completed | Baylor College of Medicine | 11 | 2017-11-15 | 2024-12-04 |
Showing 20 of 37. Sign in to see all of them.
Camurati-Engelmann Syndrome (14) · Osteogenesis Imperfecta (11) · Osteopetrosis (5) · Achondroplasia (3) · Neoplasms (3) · Anemia (2) · Anemia, Aplastic (2) · Anemia, Sickle Cell (2) · Breast Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (2) · Cytopenia (2) · Hematologic Neoplasms (2) · Leukemia (2) · Leukemia, Myeloid, Acute (2) · Lymphoma, Non-Hodgkin (2)
Bone Diseases (37) · Bone Diseases, Developmental (37) · Musculoskeletal Diseases (37) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (33) · Genetic Diseases, Inborn (32) · Skin and Connective Tissue Diseases (14) · Connective Tissue Diseases (12) · Collagen Diseases (11) · Neoplasms (8) · Neoplasms by Site (8) · Neoplasms by Histologic Type (6) · Immune System Diseases (5) · Metabolic Diseases (5) · Nutritional and Metabolic Diseases (5)
AP 1903 reagent (2) · Cisplatin (2) · Cyclophosphamide (2) · bintrafusp alfa protein, human (2) · 130-nm albumin-bound paclitaxel (1) · Betamethasone Valerate (1) · Bevacizumab (1) · Bone Marrow Transplantation (1) · Busulfan (1) · Calcium (1) · Carboplatin (1) · Cyclosporine (1) · Fenretinide (1) · Gemcitabine (1) · Hematopoietic Stem Cell Transplantation (1)
Baylor College of Medicine (3) · Bellicum Pharmaceuticals (2) · BioMarin Pharmaceutical (2) · Eli Lilly and Company (2) · Sanofi (2) · St. Jude Children's Research Hospital (2) · Abbisko Therapeutics Co, Ltd (1) · Amgen (1) · Angitia Incorporated Limited (1) · Children's Hospital Los Angeles (1) · Christian Medical College, Vellore, India (1) · EMD Serono Research & Development Institute, Inc. (1) · Emory University (1) · FBD Biologics Limited (1) · Fondazione Telethon (1)
United States (26) · Spain (5) · Italy (4) · Australia (3) · Canada (3) · France (3) · China (2) · Germany (2) · Japan (2) · Austria (1) · Greece (1) · Hungary (1) · India (1) · Pakistan (1) · Sweden (1)
Kimberly Kasow, DO (2) · Alix Seif, MD (1) · Andrew M Scott, MBBS (1) · Brendan Lee, M.D., Ph.D. (1) · Charlie Qi, MD (1) · Chen Li, Master (1) · Doris Fadoju, MD (1) · Helen Heslop, MD (1) · Hisham Abdel-Azim, MD (1)
PMID 28390753, PMID 31472446, PMID 33008091, PMID 34007848, PMID 34548321, PMID 35113812, PMID 35223854, PMID 35410255, PMID 36552855, PMID 38261781, PMID 38834319, PMID 39214047, PMID 42470570
2015 (1), 2016 (1), 2017 (1), 2019 (1), P01CA094237 (1)